Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5h credit for physicians, pharmacists, and nurses.
DM2 Therapy and Cardiorenal Outcomes
This activity is supported by educational grants from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. In case you missed the tweetorial on Twitter...
Review of Insertable Cardiac Monitors
This activity is supported by educational grants from Abbott Cardiovascular, AstraZeneca US, Bayer AG, and Novo Nordisk. In case you missed the...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.
Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.
OK, this is exciting. It's time to visit with our esteemed colleague in France, @gabrielsteg. Join here Monday for the launch of a new tweetorial, accredited for #physicians, #nurses, & #pharmacists, on the role of #DAPT in patients with CAD & high-risk features who haven't . . .
#CardioEd #CardioTwitter #Cardiology #nephjc #nephrology #NephTwitter #neph #endocrinologist #diabetescare. This is your source for joint-accredited CE/#CME in cardiometabolic medicine. All free, all expert authors! Need proof? Go to http://www.cardiometabolic-ce.com & earn more credit!
great summary https://twitter.com/cardiomet_CE/status/1405452387653980162
41) Here’s a nice algorithm to follow in the management of chronic hyperkalemia.